Uncoupling of oxidative phosphorylation by curcumin: Implication of its cellular mechanism of action

Biochemical and Biophysical Research Communications

Volumn 389, Issue 1, 2009, Pages 187-192

  Lim, Han Wern ^a   Lim, Hwee Ying ^a   Wong, Kim Ping ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

6 Ketocholestanol; Curcumin; F0F1 ATPase; Protonophore; Respiratory inhibitor; Uncoupler

Indexed keywords

2,4 DINITROPHENOL; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; CARBONYL CYANIDE 4 (TRIFLUOROMETHOXY)PHENYLHYDRAZONE; CURCUMIN; ENZYME ACTIVATOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; STAT3 PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; BIOSYNTHESIS; DRUG MECHANISM; ENZYME ACTIVITY; HUMAN; HUMAN CELL; ISOLATED LIVER; LIVER MITOCHONDRION; MALE; MITOCHONDRIAL RESPIRATION; NONHUMAN; OXIDATIVE PHOSPHORYLATION; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION;

ADENOSINE TRIPHOSPHATE; ADOLESCENT; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; CELL LINE, TUMOR; CURCUMIN; HUMANS; MALE; MITOCHONDRIA, LIVER; OXIDATIVE PHOSPHORYLATION; PROTON-TRANSLOCATING ATPASES; RATS; RATS, WISTAR; UNCOUPLING AGENTS;

CURCUMA LONGA; RATTUS;

EID: 70349096755     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.08.121     Document Type: Article

References (42)

1. Karunagaran D., Rashmi R., and Kumar T.R. Induction of apoptosis by curcumin and its application for cancer therapy. Curr. Cancer Drug Targets 5 (2005) 117-129
2. Syng-Ai C., Kumari A.L., and Khar A. Effect of curcumin on normal and tumor cells: role of glutathione and bcl-2. Mol. Cancer Ther. 3 (2004) 1101-1108
3. Cao J., Liu Y., Jia L., Zhou H.M., Kong Y., Yang G., Jiang L.P., Li Q.J., and Zhong L.F. Curcumin induces apoptosis through mitochondrial hyperpolarization and mtDNA damage in human hepatoma G2 cells. Free Radic. Biol. Med. 43 (2007) 968-975
4. Hatcher H., Planalp R., Cho J., Torti F.M., and Torti S.V. Curcumin: from ancient medicine to current clinical trials. Cell. Mol. Life Sci. 65 (2007) 1631-1652
5. Morin D., Barthélémy S., Zini R., Labidalle S., and Tillement J.P. Curcumin induces the mitochondrial permeability transition pore mediated by membrane protein thiol oxidation. FEBS Lett. 495 (2001) 131-136
6. Piwocka K., Zabłocki K., Wieckowski M.R., Skierski J., Feiga I., Szopa J., Drela N., Wojtczak L., and Sikora E. A novel apoptosis-like pathway, independent of mitochondria and caspases, induced by curcumin in human lymphoblastoid T (Jurkat) cells. Exp. Cell Res. 249 (1999) 299-307
7. Ligeret H., Barthélémy S., Bouchard Doulakas G., Carrupt P.A., Tillement J.P., Labidalle S., and Morin D. Fluoride curcumin derivatives: new mitochondrial uncoupling agents. FEBS Lett. 569 (2004) 37-42
8. Starkov A.A., Dedukhova V.I., and Skulachev V.P. 6-Ketocholestanol abolishes the effect of the most potent uncouplers of oxidative phosphorylation in mitochondria. FEBS Lett. 355 (1994) 305-308
9. Starkov A.A., Bloch D.A., Chernyak B.V., Dedukhova V.I., Mansurova S.E., Severina I.I., Simonyan R.A., Vygodina T.V., and Skulachev V.P. 6-Ketocholestanol is a recoupler for mitochondria, chromatophores and cytochrome oxidase proteoliposomes. Biochim. Biophys. Acta 1318 (1997) 159-172
10. Morin D., Zini R., Berdeaux A., and Tillement J.P. Effect of the mitochondrial transition pore inhibitor, S-15176, on rat liver mitochondria: ATP synthase modulation and mitochondrial uncoupling induction. Biochem. Pharmacol. 72 (2006) 911-918
11. Nicholls D.G. An introduction to the chemiosmotic theory. Bioenergetics. first ed. (1982), Academic Press, London 25-96
12. Yu S., Shen G., Khor T.O., Kim J.H., and Kong A.N. Curcumin inhibits Akt/mammalian target of rapamycin signaling through protein phosphatase-dependent mechanism. Mol. Cancer Ther. 7 (2008) 2609-2620
13. Lee Y.K., Lee W.S., Hwang J.T., Kwon D.Y., Surh Y.J., and Park O.J. Curcumin exerts antidifferentiation effect through AMPKalpha-PPAR-gamma in 3T3-L1 adipocytes and antiproliferatory effect through AMPKalpha-COX-2 in cancer cells. J. Agric. Food Chem. 57 (2009) 305-310
14. Zhang X., Vincent A.S., Halliwell B., and Wong K.P. A mechanism of sulfite neurotoxicity: direct inhibition of glutamate dehydrogenase. J. Biol. Chem. 279 (2004) 43035-43045
15. Palloti F., and Lenaz G. Isolation and subfractionation of mitochondria from animal cells and tissue culture lines. Methods Cell Biol. 65 (2001) 1-35
16. Kuznetsov A.V., Renner K., and Gnaiger E. Mitochondrial respiration medium-MiR05. MiPNet 8.5 (2003) 1-3
17. Williams N., Amzel L.M., and Pedersen P.L. Proton ATPase of rat liver mitochondria: a rapid procedure for purification of a stable, reconstitutively active F1 preparation using a modified chloroform method. Anal. Biochem. 140 (1984) 581-588
18. Barrientos A. In vivo and in organelle assessment of OXPHOS activities. Methods 26 (2002) 307-316
19. Vincent A.S., Lim B.G., Tan J., Whiteman M., Cheung N.S., Halliwell B., and Wong K.P. Sulfite-mediated oxidative stress in kidney cells. Kidney Int. 65 (2004) 393-402
20. Ng L.E., Halliwell B., and Wong K.P. Nephrotoxic cell death by diclofenac and meloxicam. Biochem. Biophys. Res. Commun. 369 (2008) 837-877
21. Mingatto F.E., dos Santos A.C., Rodrigues T., Pigoso A.A., Uyemura S.A., and Curti C. Effects of nimesulide and its reduced metabolite on mitochondria. Br. J. Pharmacol. 131 (2000) 1154-1160
22. Brautigan D.L., Ferguson-Miller S., and Margoliash E. Mitochondrial cytochrome c: preparation and activity of native and chemically modified cytochrome c. Methods Enzymol. 53 (1978) 128-164
23. Varela A.T., Gomes A.P., Simões A.M., Teodoro J.S., Duarte F.V., Rolo A.P., and Palmeira C.M. Indirubin-3′-oxime impairs mitochondrial oxidative phosphorylation and prevents mitochondrial permeability transition induction. Toxicol. Appl. Pharmacol. 233 (2008) 179-185
24. Pedersen P.L., and Morris H.P. Uncoupler-stimulated adenosine triphosphatase activity. Deficiency in intact mitochondria from Morris hepatomas and ascites tumor cells. J. Biol. Chem. 249 (1974) 3327-3334
25. Haworth R.A., and Hunter D.R. Control of the mitochondrial permeability transition pore by high-affinity ADP binding at the ADP/ATP translocase in permeabilized mitochondria. J. Bioenerg. Biomembr. 32 (2000) 91-96
26. Novgorodov S.A., Gudz T.I., Milgrom Y.M., and Brierley G.P. The permeability transition in heart mitochondria is regulated synergistically by ADP and cyclosporin A. J. Biol. Chem. 267 (1992) 16274-16282
27. Terada H. The interaction of highly active uncouplers with mitochondria. Biochim. Biophys. Acta 639 (1981) 225-242
28. Zheng J., and Ramirez V.D. Inhibition of mitochondrial proton FoF1-ATPase/ATP synthase by polyphenolic phytochemicals. Br. J. Pharmacol. 130 (2000) 1115-1123
29. Hayashi J.I., Yonekawa H., Gotoh O., and Tagashira Y. Unique uncoupler-stimulation pattern of mitochondrial ATPase activity of tumor cells, brain and fetal liver. Biochem. Biophys. Res. Commun. 92 (1980) 261-267
30. Chan W.H., Wu H.Y., and Chang W.H. Dosage effects of curcumin on cell death types in a human osteoblast cell line. Food Chem. Toxicol. 44 (2006) 1362-1371
31. Moreland D.E. Effects of toxicants on oxidative phosphorylation and photophosphorylation. In: Hodgson E., and Levi P.E. (Eds). Introduction to Biochemical Toxicology. second ed. (1994), Appleton & Lange 355-357
32. Tokutake N., Miyoshi H., and Fujita T. Electron transport inhibition of the cytochrome bc1 complex of rat-liver mitochondria by phenolic uncouplers. Biochim. Biophys. Acta 1057 (1991) 377-383
33. Brandt U., Schubert J., Geck P., and von Jagow G. Uncoupling activity and physicochemical properties of derivatives of fluazinam. Biochim. Biophys. Acta 1101 (1992) 41-47
34. Chakravarti N., Myers J.N., and Aggarwal B.B. Targeting constitutive and interleukin-6-inducible signal transducers and activators of transcription 3 pathway in head and neck squamous cell carcinoma cells by curcumin (diferuloylmethane). Int. J. Cancer 119 (2006) 1268-1275
35. Soltoff S.P. Evidence that tyrphostins AG10 and AG18 are mitochondrial uncouplers that alter phosphorylation-dependent cell signaling. J. Biol. Chem. 279 (2004) 10910-10918
36. Yokogami K., Wakisaka S., Avruch J., and Reeves S.A. Serine phosphorylation and maximal activation of STAT3 during CNTF signaling is mediated by the rapamycin target mTOR. Curr. Biol. 10 (2000) 47-50
37. Kim J.H., Kim J.E., Liu H.Y., Cao W., and Chen J. Regulation of interleukin-6-induced hepatic insulin resistance by mammalian target of rapamycin through the STAT3-SOCS3 pathway. J. Biol. Chem. 283 (2008) 708-715
38. Ghosh A.K., Kay N.E., Secreto C.R., and Shanafelt T.D. Curcumin inhibits prosurvival pathways in chronic lymphocytic leukemia B cells and may overcome their stromal protection in combination with EGCG. Clin. Cancer Res. 15 (2009) 1250-1258
39. Henin N., Vincent M.F., Gruber H.E., and Van den Berghe G. Inhibition of fatty acid and cholesterol synthesis by stimulation of AMP-activated protein kinase. FASEB J. 9 (1995) 541-546
40. Weisberg S.P., Leibel R., and Tortoriello D.V. Dietary curcumin significantly improves obesity-associated inflammation and diabetes in mouse models of diabesity. Endocrinology 149 (2008) 3549-3558
41. Winder W.W. Can patients with type 2 diabetes be treated with 5′-AMP-activated protein kinase activators?. Diabetologia 51 (2008) 1761-1764
42. Shoba G., Joy D., Joseph T., Majeed M., Rajendran R., and Srinivas P.S. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med. 64 (1998) 353-356